CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company
BioRestorative Therapies, Inc.
Sign in to watch- Ticker
- BRTX
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 301341024
- Phone
- (631) 760-8100
- Business address
- 40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
- Former names
- Stem Cell Assurance, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-08-28 | Tonna Paul Jude Director | Purchase | +35,000 | $0.27 | $9K | 106,000 |
| 2019-08-28 | Radov A. Jeffrey Director | Purchase | +3,000 | $0.28 | $840 | 24,500 |
| 2019-08-27 | Tonna Paul Jude Director | Purchase | +35,000 | $0.28 | $10K | 71,000 |
| 2019-08-27 | Radov A. Jeffrey Director | Purchase | +3,000 | $0.27 | $810 | 21,500 |
| 2019-08-27 | Weinreb Mark CEO and Chairman of the Board | Purchase | +2,500 | $0.25 | $625 | 87,500 |
| 2019-08-27 | Weinreb Mark CEO and Chairman of the Board | Purchase | +2,500 | $0.26 | $650 | 90,000 |
| 2019-08-27 | ALSTODT LANCE EVP and Chief Strategy Officer | Purchase | +100 | $0.26 | $26 | 10,100 |
| 2019-08-27 | ALSTODT LANCE EVP and Chief Strategy Officer | Purchase | +3,700 | $0.27 | $999 | 13,800 |
| 2019-08-27 | ALSTODT LANCE EVP and Chief Strategy Officer | Purchase | +6,200 | $0.28 | $2K | 20,000 |
| 2019-08-26 | Silva Francisco VP of Research and Development | Purchase | +3,500 | $0.29 | $1K | 12,116 |
| 2019-08-26 | Silva Francisco VP of Research and Development | Purchase | +4,000 | $0.25 | $1K | 17,003 |
| 2019-08-26 | Radov A. Jeffrey Director | Purchase | +3,000 | $0.25 | $750 | 18,500 |
| 2019-08-23 | Radov A. Jeffrey Director | Purchase | +3,000 | $0.26 | $790 | 15,500 |
| 2019-08-22 | Broadrick Dale 10% owner | Purchase | +130,120 | $0.28 | $37K | 3,616,332 |
| 2019-08-22 | Silva Francisco VP of Research and Development | Purchase | +8,446 | $0.23 | $2K | 8,616 |
| 2019-08-22 | Silva Francisco VP of Research and Development | Purchase | +8,928 | $0.28 | $2K | 13,003 |
| 2019-08-22 | Broadrick Dale 10% owner | Purchase | +148,317 | $0.29 | $42K | 3,614,529 |
| 2019-08-22 | Weinreb Mark CEO and Chairman of the Board | Purchase | +1,700 | $0.29 | $493 | 81,700 |
| 2019-08-22 | Weinreb Mark CEO and Chairman of the Board | Purchase | +1,300 | $0.26 | $339 | 83,000 |
| 2019-08-22 | Weinreb Mark CEO and Chairman of the Board | Purchase | +2,000 | $0.24 | $480 | 85,000 |
Page 13 of 35 · 690 trades